🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The pharmacokinetic (PK) profile of tralokinumab (CAT-354) will be studied ...
Status
Completed
Location
Research Site
Start Date
2012-06
Trial ID
NCT01592396
Treatments Being Tested
To compare bioavailability and pharmacokinetics of CAT-354 following subcut...
Status
Completed
Location
MDS Pharma Services (US) Inc.
Start Date
2008-04-11
Trial ID
NCT00638989
Treatments Being Tested
To investigate the effects of CAT-354 on airway hyper-responsiveness (AHR) ...
Status
Terminated
Location
St. Vincents Hospital, Thoracic Medicine Unit
Start Date
2008-01
Trial ID
NCT00640016
Treatments Being Tested
The primary objective of this study is to evaluate the pharmacokinetics (PK...
Status
Completed
Location
Celerion
Start Date
2014-03-19
Trial ID
NCT02085473
Treatments Being Tested
This is a Phase 2a, randomized, double-blind, placebo-controlled, parallel-...
Status
Completed
Location
Research Site
Start Date
2009-06
Trial ID
NCT00873860
Treatments Being Tested
The purpose of this study is to determine whether the addition of tralokinu...
Status
Completed
Location
Research Site
Start Date
2011-08
Trial ID
NCT01402986
Treatments Being Tested
The purpose of the study is to evaluate the safety and tolerability of mult...
Status
Completed
Location
Research Site
Start Date
2014-01
Trial ID
NCT02036580
Treatments Being Tested
The study is designed to evaluate the clinical efficacy and safety of tralo...
Status
Completed
Location
Research Site
Start Date
2012-03
Trial ID
NCT01482884
Treatments Being Tested
To assess the safety of the administration of the drug (CAT-354) in healthy...
Status
Completed
Location
Research Site
Start Date
2010-04
Trial ID
NCT01093040
The study includes participants with moderate asthma who were randomly assi...
Status
Terminated
Location
Chiltern International Limited
Start Date
2006-09-29
Trial ID
NCT00974675
Treatments Being Tested